NORTHPOINTE CAPITAL LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 168 filers reported holding REPLIGEN CORP in Q4 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHPOINTE CAPITAL LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2015$2,329,000
-43.3%
76,718
-63.0%
0.25%
-48.9%
Q4 2014$4,107,000
-42.8%
207,437
-42.4%
0.49%
-35.3%
Q3 2014$7,176,000
-3.0%
360,412
+11.0%
0.76%
+6.7%
Q2 2014$7,399,000
-37.6%
324,652
-64.8%
0.71%
-40.6%
Q1 2014$11,851,000
-44.3%
921,572
-40.9%
1.20%
-36.0%
Q4 2013$21,283,000
+5.8%
1,560,320
-14.0%
1.88%
-20.4%
Q3 2013$20,122,000
+10.1%
1,814,529
-18.2%
2.36%
+11.9%
Q2 2013$18,282,0002,218,5772.11%
Other shareholders
REPLIGEN CORP shareholders Q4 2014
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders